These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 1327393

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Preclinical characterization of MDL 27,192 as a potential broad spectrum anticonvulsant agent with neuroprotective properties.
    Kehne JH, Kane JM, Chaney SF, Hurst G, McCloskey TC, Petty MA, Senyah Y, Wolf HH, Zobrist R, White HS.
    Epilepsy Res; 1997 Apr; 27(1):41-54. PubMed ID: 9169290
    [Abstract] [Full Text] [Related]

  • 5. The pharmacological properties of the imidazobenzodiazepine, FG 8205, a novel partial agonist at the benzodiazepine receptor.
    Tricklebank MD, Honoré T, Iversen SD, Kemp JA, Knight AR, Marshall GR, Rupniak NM, Singh L, Tye S, Watjen F.
    Br J Pharmacol; 1990 Nov; 101(3):753-61. PubMed ID: 1963808
    [Abstract] [Full Text] [Related]

  • 6. Characterization of [3H]thiocolchicoside binding sites in rat spinal cord and cerebral cortex.
    Balduini W, Cimino M, Depoortere H, Cattabeni F.
    Eur J Pharmacol; 1999 Jul 02; 376(1-2):149-57. PubMed ID: 10440100
    [Abstract] [Full Text] [Related]

  • 7. Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor.
    Carter RB, Wood PL, Wieland S, Hawkinson JE, Belelli D, Lambert JJ, White HS, Wolf HH, Mirsadeghi S, Tahir SH, Bolger MB, Lan NC, Gee KW.
    J Pharmacol Exp Ther; 1997 Mar 02; 280(3):1284-95. PubMed ID: 9067315
    [Abstract] [Full Text] [Related]

  • 8. Urea-induced myoclonus: medullary glycine antagonism as mechanism of action.
    Chung E, Yocca F, Van Woert MH.
    Life Sci; 1985 Mar 18; 36(11):1051-8. PubMed ID: 2983163
    [Abstract] [Full Text] [Related]

  • 9. Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors.
    McCabe RT, Wasterlain CG, Kucharczyk N, Sofia RD, Vogel JR.
    J Pharmacol Exp Ther; 1993 Mar 18; 264(3):1248-52. PubMed ID: 8383742
    [Abstract] [Full Text] [Related]

  • 10. Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding site.
    Baron BM, Harrison BL, McDonald IA, Meldrum BS, Palfreyman MG, Salituro FG, Siegel BW, Slone AL, Turner JP, White HS.
    J Pharmacol Exp Ther; 1992 Sep 18; 262(3):947-56. PubMed ID: 1388205
    [Abstract] [Full Text] [Related]

  • 11. Reversal of the action of amino acid antagonists by barbiturates and other hypnotic drugs.
    Bowery NG, Dray A.
    Br J Pharmacol; 1978 May 18; 63(1):197-215. PubMed ID: 206305
    [Abstract] [Full Text] [Related]

  • 12. Anticonvulsant action of chlormethiazole is prevented by subconvulsive amounts of strychnine and aminophylline but not by bicuculline and picrotoxin.
    Pilip S, Urbańska EM, Swiader M, Włodarczyk D, Kleinrok Z, Czuczwar SJ, Turski WA.
    Pol J Pharmacol; 2000 May 18; 52(4):267-73. PubMed ID: 11345482
    [Abstract] [Full Text] [Related]

  • 13. MDL 26,479: a potential cognition enhancer with benzodiazepine inverse agonist-like properties.
    Miller JA, Dudley MW, Kehne JH, Sorensen SM, Kane JM.
    Br J Pharmacol; 1992 Sep 18; 107(1):78-86. PubMed ID: 1330168
    [Abstract] [Full Text] [Related]

  • 14. A potent antagonist of the strychnine insensitive glycine receptor has anticonvulsant properties.
    Sheardown MJ, Drejer J, Jensen LH, Stidsen CE, Honoré T.
    Eur J Pharmacol; 1989 Dec 19; 174(2-3):197-204. PubMed ID: 2560979
    [Abstract] [Full Text] [Related]

  • 15. MDL 27,531 reduces spontaneous hindlimb contractions in rats with chronic transections of the spinal cord.
    Kehne JH, Ketteler HJ, Kane JM, McCloskey TC, Senyah Y, Palfreyman MG.
    Neurosci Lett; 1992 Nov 23; 147(1):101-5. PubMed ID: 1480315
    [Abstract] [Full Text] [Related]

  • 16. Thermodynamics of agonist and antagonist interaction with the strychnine-sensitive glycine receptor.
    Ruiz-Gómez A, García-Calvo M, Vázquez J, Marvizón JC, Valdivieso F, Mayor F.
    J Neurochem; 1989 Jun 23; 52(6):1775-80. PubMed ID: 2542450
    [Abstract] [Full Text] [Related]

  • 17. Glycine antagonists structurally related to 4,5,6,7-tetrahydroisoxazolo [5,4-c]pyridin-3-ol inhibit binding of [3H]strychnine to rat brain membranes.
    Braestrup C, Nielsen M, Krogsgaard-Larsen P.
    J Neurochem; 1986 Sep 23; 47(3):691-6. PubMed ID: 3016180
    [Abstract] [Full Text] [Related]

  • 18. Antagonism of L-glycine to seizures induced by L-kynurenine, quinolinic acid and strychnine in mice.
    Lapin IP.
    Eur J Pharmacol; 1981 May 22; 71(4):495-8. PubMed ID: 7250201
    [Abstract] [Full Text] [Related]

  • 19. Modulation of seizure susceptibility in the mouse by the strychnine-insensitive glycine recognition site of the NMDA receptor/ion channel complex.
    Singh L, Oles RJ, Tricklebank MD.
    Br J Pharmacol; 1990 Feb 22; 99(2):285-8. PubMed ID: 1691674
    [Abstract] [Full Text] [Related]

  • 20. Anticonvulsant profile of MDL 27,266: an orally active, broad-spectrum anticonvulsant agent.
    White HS, Patel S, Meldrum BS.
    Epilepsy Res; 1992 Sep 22; 12(3):217-26. PubMed ID: 1396547
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.